chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mom reports swelling at the injection site (right arm) noted on 04/25/2001.  There were no other vaccinations given that date, child is fully recovered.  follow up complete.
12 days post vaccine, achiness at vaccine site and 3 X 4 inch area of redness.
Body aches starting 3/17/06; fever (starting 3/17/06) - mother does not have thermometer but says she feels "hot" to the touch.
The first 2 doses were not too bad. I just felt  tired  within 24 hours and recovered  noon. The booster (3rd dose) had the same effect as the first 2 doses. In addition, about getting the booster 40 hours, both eyes were extremely painful and seemed inflamed.
several hrs p/vax low grade temp; that eveningt103-105 treated w/APAP; 24 hrs p/vax devel hives; 48 hrs p/vax devel swelling of lt knee, also c/o abdo pain; examined 8OCT93 nl exam;
quarter size lump noted rt axilla approx 24hrs p/vax-mild tenderness;no fever;warm soaks each noc;resolved p/approx 2wks;
Chapped lips; Moderna rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of CHAPPED LIPS (Chapped lips) and VACCINATION SITE RASH (Moderna rash at the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 025L20A) for COVID-19 vaccination.     Concomitant products included METOPROLOL, HYDROCHLOROTHIAZIDE, ATORVASTATIN, ASPIRIN [ACETYLSALICYLIC ACID], COLECALCIFEROL (VITAMIN D3), FISH OIL and VITAMIN B12 [VITAMIN B12 NOS] for an unknown indication.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHAPPED LIPS (Chapped lips) and VACCINATION SITE RASH (Moderna rash at the injection site). At the time of the report, CHAPPED LIPS (Chapped lips) had not resolved and VACCINATION SITE RASH (Moderna rash at the injection site) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication include Chapstick for patient lips
Information has been received from a pharmacist concerning an 18 year old female who on 06-AUG-2007 was vaccinated with a first dose of Gardasil.  On 06-AUG-2007 the patient experienced syncope shortly after the dose was administered.  Subsequently, the patient recovered from syncope.  Additional information has been requested.
Patient came in on 9/18/21 with hives all over his arms and trunk. He said it started the day he got the vaccine. I recommended that he take some Benedryl and to let his doctor know about this reaction. I documented the allergy in our system as well.
Headache that lasted 24 hours, nausea that lasted 24 hours, vomiting that lasted 12 hours, and body aches and pains that continue at this time , 36 hours later.  The headaches have mostly subsided, vomiting has ceased, nausea has mostly ceased, although  it may continue at bedtime much like last evening.
Case PHEH2016US025363, is an initial spontaneous report received from a pharmacist on 29 Sep 2016. This report refers to a patient of unknown age and gender. Medical history and concomitant medications were not reported. The patient was vaccinated with expired FLUVIRIN (batch number: not reported) on 22 Sep 2016. The pharmacist stated that, the patient received FLUVIRIN at hospital. No adverse event was reported following this maladministration.
I began to get a major eczema flair up, rash on my left arm, right arm, left calf,  it is constantly getting worse. I went to see Dermatologist, they started me on a new medication, pimecrolimus, to combat this flair up, eczema is starting to improve some of the areas however it is still bad.
No effects - reporting only. 4-17-13 I diluted the ZOSTAVAX vaccine w/ BOOSTRIX by mistake and gave injection Sub Q. I informed patient immediately and began making calls Merck Glaxo CDC FDA.
On 11/15/00, states she has been out of work all week due to soreness and swelling in arm. Visited private physician, who stated she had cellulitis in right arm.
Patient had a warm, red area surrounding the injection site that was tender to touch. It was in the area that the KINRIX was placed.
8 hours later, beginning to get sore and stiff. For 2 days total (after shot), flu like symptoms, uncomfortable gastrointestinal issues, headache, red arm and hot and itchy. For total of 5 days after shot, red arm, hot with fever on arm, extremely sore arm, itchiness that would not quit and quite unbearable. Topical itch creams didn't work. Cool rags didn't help. ADVIL didn't help. Finally wore off.
I developed Bells Palsy affecting the left side of face On 04Jul, 4 months after my 2nd Pfizer vaccine on 04Mar; This is a spontaneous report from a contactable consumer (patient). A 74-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EN6200), via unspecified route of administration, administered in arm left on 04Mar2021 (at the age of 74-years-old and she was not pregnant at the time of vaccination) as Dose 2,Single for COVID-19 immunization. The patient's medical history was none. Other medications in two weeks included atorvastatin calcium (LIPITOR) 10 mg daily. There was no other vaccine in four weeks. There was no covid prior vaccination and not tested COVID post vaccination. There was no known allergies. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: EL9265), via unspecified route of administration, administered in arm left on unspecified date as DOSE 2, SINGLE for COVID-19 immunisation at hospital. The patient experienced Bell's Palsy affecting the left side of face on 04Jul2021 at 6:00 AM, 4 months after my 2nd Pfizer vaccine on 04Mar2021. The adverse event resulted into Emergency room visit, Hospitalization for one day. She received treatments for adverse event included CT Scan, MRI, medication. The patient underwent lab tests and procedures included CT Scan, MRI on unspecified date. The outcome of event was not recovered.  No follow-up attempts were possible. No further information was expected.
Skin inflamed at injection site.  Approximately 7 days after injection, the skin rash became itchy and red.
R09.02 HYPOXEMIA 5/26/2023 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED
Mild transient dizziness after injection. Lt shoulder pain, erythematous macular lesion over shoulder, approximately 2.5 ". Pain with lifting shoulder > 45 degrees noted the next evening after the injection.
is having a very bad day; feeling fatigued; labyrinthitis, an inner ear thing, and it seems to come more after the shot; This spontaneous case was reported by a patient and describes the occurrence of LABYRINTHITIS (labyrinthitis, an inner ear thing, and it seems to come more after the shot), FEELING ABNORMAL (is having a very bad day) and FATIGUE (feeling fatigued) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LABYRINTHITIS (labyrinthitis, an inner ear thing, and it seems to come more after the shot), FEELING ABNORMAL (is having a very bad day) and FATIGUE (feeling fatigued). At the time of the report, LABYRINTHITIS (labyrinthitis, an inner ear thing, and it seems to come more after the shot), FEELING ABNORMAL (is having a very bad day) and FATIGUE (feeling fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was provided No concomitant medication was provided
08/27/22 presents to ED for "fall". PMHx of "a-fib, DVT/PE on Eliquis, upper and lower spinal stenosis"
Patient had pain and swelling that started the same day of vaccination. Pain has been sharp with cramping in the hand periodically since. Today, 11/17/21, pain became more frequent and worse and a red, circular swelling appeared at site of injection. Size is about 2 inches in diameter.
Started plaquenil 12/18 due to new diagnosis of undifferentiated connective tissue disease per rheumatologist. Noticed itching and slight rash. Received Covid Pfizer BioNTech vaccine on 12/22. Rash became increasing worse each day starting 12/23, facial swelling 12/25 and 12/26. Hives in throat 12/26. Hives on tongue, continues head to toe hives and extreme itching 12/29. Last dose of plaquenil was 12/22.
I had a mild anaphylactic reaction five minutes after getting the vaccine.  The hives and tight throat went away after several doses of medication. The redness and itching last 4-5 days. I had to stay on Benadryl and Zyrtec to help with the redness and itching.  My job sent me to the ER to be monitored after getting the shot until I went home. The fatigue lasted for a whole week.
Moderna COVID-19 Vaccine EUA  Underage individual documented age not under 18 years.  Dose 1 given.  No adverse events known.
Fatigue, headache, chills, fever, pain at injection site, nausea, joint pain, muscle pain
10-12 pts had local swelling & redness @ inject site; vax contains particles that will not resuspend;
Before vaccine went for sonogram, no signs of blood clot Vein doctor did more advanced sonogram and was negative again for clots. A few days later clots started appearing on varicose veins.  First clot started inside of knee, thought it was a boil, it was a big red figure with a dark center, doctor diagnosed with superficial blood clots (about 10 days after vaccine) On the 10th when seeing doctor blood pressure shot up, had to double lisinopril. Patient reports history of smoking.
Pt c/o shaking, flu-like s/s, (L arm swelling, localized arm redness, heat + pain in bicep + tricep area.
Pt vaccinated with DTP one of two pt developed urticaria 20 hrs after immunization.
OBLONGED SHAPE RED RASH(PATCH)slightly rasied 10.5cm in width and 13.5cm in height on right thigh; patient reports itching and feeling warm at the site
Diarrhea next day lasting about a day. Two days after vaccine, asthma like symptoms reported, on 2/21/16 general malaise, and hives. 2/22/16 fever and respiratory symptoms. 2/26 sinus infection, 3/2 sinus infection, antibiotic change by PMD.
The regularly scheduled  menstrual cycle after dose 2, very heavy clotting and bleeding occurred for one day. This was not normal for me at all, but this also happened after dose 1  of Covid-19 during regularly scheduled menstrual cycle as well.  It was jaw-dropping for sure.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2011, the patient was inoculated with ZOSTAVAX by a physician as recommended for routine adult health maintenance and for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 10-AUG-2015, the patient was treated at an urgent care center for a persistent and severe vesicular rash, which was diagnosed as shingles. She was prescribed valacyclovir for management of her painful symptoms and chronic pain. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Positive case of COVID; Positive case of COVID; strong fever; headaches; bodychills; body aches; fatigue; coughing; congestion; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 30 year-old male patient received bnt162b2 (BNT162B2), administration date 16Mar2021 (Lot number: EL3247) at the age of 29 years as dose 2, single and administration date 23Feb2021 (Lot number: EL3247) at the age of 29 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 09Jan2022, outcome "recovering" and all described as "Positive case of COVID"; PYREXIA (non-serious) with onset Jan2022, outcome "recovering", described as "strong fever"; HEADACHE (non-serious) with onset Jan2022, outcome "recovering", described as "headaches"; CHILLS (non-serious) with onset Jan2022, outcome "recovering", described as "bodychills"; PAIN (non-serious) with onset Jan2022, outcome "recovering", described as "body aches"; FATIGUE (non-serious) with onset Jan2022, outcome "recovering", described as "fatigue"; COUGH (non-serious) with onset Jan2022, outcome "recovering", described as "coughing"; NASAL CONGESTION (non-serious) with onset Jan2022, outcome "recovering", described as "congestion". The patient had strong fever, headaches, bodychills, body aches, fatigue, coughing and congestion for a week. Post vaccination, the patient was tested covid-19 positive. The patient underwent the following laboratory tests and procedures: sars-cov-2 antibody test: (07Jan2022) negative, notes: Nasal Swab; sars-cov-2 test: (08Jul2021) negative, notes: Nasal Swab; (09Jan2022) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19, pyrexia, headache, chills, pain, fatigue, cough, nasal congestion.
Extreme fatigue, sweating, swollen glands, shortness of breath 15 minutes after getting the shot. Took Claritin, but it didn't help. Coughing and wheezing, dry throat, itching eyes by 2:30 PM. Took 50 mg of Benadryl. That helped some. Took Benadryl at bedtime. The site of intradermal shot was red, hard, swollen, and painful down to her elbow. Most symptoms lessened by the next morning. on 10/11/13, still reports shortness of breath, cough, some wheezing, and glands swollen. Has had other vaccines in the past, TB, MMR, and Hep B, but did not have any reactions to those injections.
This spontaneous report was received from a licensed vocational nurse and refers to multiple unspecified patients of unknown age and gender. The patients' pertinent medical history and concurrent conditions were not provided. On 16-FEB-2016, 17-FEB-2016 or 18-FEB-2016, the patients were vaccinated with RECOMBIVAX HB lot # L019298, expiration date 22-JUN-2017 (dose and route were not provided). Concomitant therapy information was not provided. On 16-FEB-2016, 17-FEB-2016 or 18-FEB-2016, there was an incorrect product storage as multiple unspecified patients received RECOMBIVAX HB that were improperly stored. No adverse events were reported. The highest temperature for the reported excursion as 48.32 F and it was during the time frame of 25 minutes. There was no previous temperature excursion. The call to report this information was because of a data logger. It was unknown if the patients sought medical attention. At the time of the report, the patients' status was unknown. This is one of several reports received from the same source. Additional information has been requested.
43 year old female physician who had onset of intense pain and weakness in her bilateral quadriceps after two hours of moderately strenuous cross country skiing on 2/16/03. She had not been hydrating herself during the skiing. The evening of 2/16/03 she noted continued thigh discomfort and also darkened urine which she dipsticked and found 3+  positive heme. She increased her oral fluids and came into the medical center on 2/17/03 for labwork and was found to have a CPK of 29, 826 (nl   0-160), normal electrolytes and normal BUN and Creat. She discussed with nephrologist who advised to continue oral hydration as treatment for rhabdomyolysis given normal renal function. She continued to have pain in her thighs and weakness with limited standing and walking tolerancee. She was seen by her Primary care physician on 2/19/03 and was noted to have slt edema to the left calf and thigh and doppler ultrasound was done to r/o DVT. This was negative. Repeat labs showed reduction of CPK to 15, 000, normal CBC, and continued normal renal function. A urinalysis was normal. No other physical findings aside from tenderness to palpation of the bilateral quads. No skin changes, bruising or rash. PMH: unremarkable. She is an active individual that in the past has had no problem tolerating bursts of increased physical activity. She had participated in a one hour spinning class the day before the skiing and was sore after that. She had not been doing spinning on a regular basis. She had the smallpox vaccination on 2/3/2003 and had a documented 'take". She had experienced some itching at the site but no other significant side effects. She denied any constitutional symptoms during the days preceding or the days of her physical activities. She had children that had been ill with a flu like illness the week prior to these symptoms but she had not had any symptoms. She had received the influenza vaccine last Fall. Her current status as off today (2/24/03)is that her thigh pain and weakness is slowly improving. She has a new CPK test pending.
Zoster ocular disease; This is a spontaneous report received from a contactable (reporting on himself). A 39-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0151 and Expiration Date was not reported) via an unspecified route of administration in Arm Left on 04Apr2021, as 1st dose, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. No known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination.  The patient was not tested for COVID-19 since the vaccination. Patient received Protein shakes - green powder within 2 weeks of vaccination. On 16Apr2021, patient experienced zoster ocular disease. The outcome of the event was re-covering.   No follow-up attempts are needed. No further information is expected.
Around 10pm, I was suddenly very tired and could not stop yawning. I typically am up until 12-1 most nights so this was out of the ordinary. While getting ready for bed I became very nauseous and almost threw up.  I had waves of nausea for around 20 minutes. When I stood up I had chills throughout my body and my skin was covered in goosebumps.  A little later, my vision started to go black and I felt dizzy and light-headed. I went to bed shortly after in hopes of sleeping it off (probably 10:45-11).  Around 2 am the following morning, I woke up and had a hot flash (could have been a fever but I did not check my temperature). I was able to fall back asleep and felt normal when I woke up at 7:30 am.
From the first dose to approximately three days I started a strange pain that I had never had in my right arm. As the days passed, the pain increased and spread in the injected arm. With the second dose despite not being in the right arm the pain increased considerably and two months after the second dose I can hardly use my right arm. But the pain is increasing more and more. More and more drugs that do not eliminate pain. Cymbalta, Norflex, Decadron, Toradol, triamcinolone and over use of counter Tylenol arthritis.
Redness and swelling and itching since 4/26/10 when he received immunes. Was instructed to use warm compresses and see if the redness will disperse and was prescribed medication as well.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Mar2021 at 11:00 as dose 1, single (Lot number: EN6206), in left arm, on 26Mar2021 at 10:30 as dose 2, single (Lot number: EP8730), in left arm, on 17Aug2021 at 11:00 as dose 3 (booster), single (Lot number: EC3132), in left arm and on 01Apr2022 at 14:00 as dose 4 (booster), single (Lot number: FJ9943), in left arm for covid-19 immunisation. The patient's relevant medical history included: "RA" (unspecified if ongoing); "over weight" (unspecified if ongoing). Concomitant medication(s) included: L-THYROXINE [LEVOTHYROXINE SODIUM], start date: 30Jun2020. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Sep2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Treatment of COVID-19; (25Sep2022) Positive, notes: Rebound Covid positive on 25Sep2022. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Patient received Xeljanz Xr (From 14Aug2022 to 11Sep2022), Simvastatin (From 30Jun2022 to 11Sep2022).
On 6-20-18 Patient C/O pain to (R) deltoid area Upon assessment she had a 4"x1.5" red raised area. Slightly warm to touch. Medical provider ordered Diphenhydramine Q6 hours x 48 hour and ice packs as tolerated.
Extremely week; tired; numbness and tingling in both legs and hands; numbness and tingling in both legs and hands; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 68 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 03Oct2021 11:00 (Lot number: FF8841) at the age of 68 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Vaccine Administration Time: 12:00, Batch/Lot No: Lot # FC3184, Location of injection: Arm Left), administration date: 12Sep2021, when the patient was 68 years old, for COVID-19 Immunization. The following information was reported: ASTHENIA (non-serious) with onset 04Oct2021 11:00, outcome "not recovered", described as "Extremely week"; FATIGUE (non-serious) with onset 04Oct2021 11:00, outcome "not recovered", described as "tired"; HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious) all with onset 04Oct2021 11:00, outcome "not recovered" and all described as "numbness and tingling in both legs and hands". Therapeutic measures were not taken as a result of asthenia, fatigue, hypoaesthesia, paraesthesia.  Additional information: Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine: No. List of any other medications the patient received within 2 weeks of vaccination: No. The event had not resulted in for death, life-threatening, prolonged hospitalisation, disabling/incapacitating or Congenital anomaly/birth defect. Adverse event Extremely week and tired, numbness and tingling in both legs and hands. Started after second dose and continued. if patient recovered: Not recovered. If treatment ae: No. Prior to vaccination, was the patient diagnosed with COVID-19: No. Since the vaccination, has the patient been tested for COVID-19: No.  No follow-up attempts are possible. No further information is expected.
PATIENT IS ONLY 16 AND RECEIVED MODERNA VACCINE AS FIRST DOSE.  NO ADVERSE SIGNS OR SYMPTOMS.